Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — longevity

What is Cardiometabolic Risk? Cardiometabolic risk refers to a collection of conditions linked to obesity and insulin resistance that increase the chances of developing type 2 diabetes, heart disease, or both. These risks rarely occur in isolation—when one appears, others often follow. That’s why proactive screening is so important.

Discover how saliva and blood cortisol testing reveal adrenal function and help diagnose stress-related hormone imbalances like fatigue, anxiety, and burnout.

A Recipe for Beating (and Preventing) Breast Cancer The latest research on natural progesterone and breast cancer clearly indicates how important it is for women to maintain healthy, normal levels of progesterone that are in proper balance with oestrogen. Doing so could not only increase many women’s chances of recovering from breast cancer — as the latest research indicates — but could also help them to avoid getting breast cancer in the first place. As Dr. John Lee and Dr. David Zava point out in their book, hormonal imbalances have reached epidemic proportions in most developed countries over the last...

A large team of scientists working on multiple continents published a research study that came to startling conclusions about breast cancer and natural progesterone. The team determined that unlike synthetic progestins, which increase breast cancer risks, natural progesterone has the potential to slow the growth of many breast cancer tumours or even shrink them. While this finding is stunning, it is not new. It is one of several conclusions about progesterone that Dr. John R. Lee, M.D. and Dr. David Zava, Ph.D. made more than a decade ago when they co-wrote the book, What Your Doctor May Not Tell You...

In our current medical paradigm, screening for cancer is considered a preventive measure by virtue of providing an earlier diagnosis. Getting an early jump on a disease process like cancer makes treatment exponentially easier and outcomes generally better. Under the current guidelines, that early jump on prostate cancer starts at age 55 for men at low to moderate risk and 40–45 for men at high risk. It takes years for cancer to grow to a detectable point after the tumour’s initial induction from a normal cell to a cancerous one. There’s been a lot of research done to determine what...